We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

15 hedge funds and large institutions have $1.3M invested in The Oncology Institute Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

15% more funds holding

Funds holding: 1315 (+2)

0.55% more ownership

Funds ownership: 5.6%6.15% (+0.55%)

53% less capital invested

Capital invested by funds: $2.77M → $1.3M (-$1.48M)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
1
Closed
2
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$7K

TOIIW Hedge Fund Activity: Q1 2023 in Review

15 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q1 2023, worth a combined $1.3M — down 53% from $2.77M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TOIIW positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Walleye Capital, adding an estimated $15.4K. The largest seller was Man Group, exiting entirely with an estimated $11.7K sold.

  • 15 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q1 2023, up from 13 in Q4 2022.
  • Funds reported $1.3M of The Oncology Institute Warrant stock for Q1 2023, down 53% quarter-over-quarter.
  • 4 funds opened new The Oncology Institute Warrant positions in Q1 2023 and 2 closed out, a net change of +2 holders.
  • The largest The Oncology Institute Warrant buyer in Q1 2023 was Walleye Capital, an estimated $15.4K added.
  • The largest The Oncology Institute Warrant seller in Q1 2023 was Man Group, an estimated $11.7K sold.

Based on aggregated 13F filings for Q1 2023.